Pure Health Holding PJSC Statistics
Total Valuation
ADX:PUREHEALTH has a market cap or net worth of AED 21.11 billion. The enterprise value is 31.65 billion.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
ADX:PUREHEALTH has 11.11 billion shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 11.11B |
| Shares Outstanding | 11.11B |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.08% |
| Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 10.54 and the forward PE ratio is 9.08. ADX:PUREHEALTH's PEG ratio is 0.62.
| PE Ratio | 10.54 |
| Forward PE | 9.08 |
| PS Ratio | 0.77 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | 5.29 |
| P/OCF Ratio | 4.28 |
| PEG Ratio | 0.62 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 7.93.
| EV / Earnings | 15.81 |
| EV / Sales | 1.16 |
| EV / EBITDA | 7.25 |
| EV / EBIT | 11.87 |
| EV / FCF | 7.93 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.35 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 4.17 |
| Debt / FCF | 4.57 |
| Interest Coverage | 3.13 |
Financial Efficiency
Return on equity (ROE) is 10.62% and return on invested capital (ROIC) is 8.79%.
| Return on Equity (ROE) | 10.62% |
| Return on Assets (ROA) | 3.15% |
| Return on Invested Capital (ROIC) | 8.79% |
| Return on Capital Employed (ROCE) | 6.30% |
| Weighted Average Cost of Capital (WACC) | 6.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.52 |
| Inventory Turnover | 15.83 |
Taxes
In the past 12 months, ADX:PUREHEALTH has paid 222.01 million in taxes.
| Income Tax | 222.01M |
| Effective Tax Rate | 9.90% |
Stock Price Statistics
The stock price has decreased by -30.56% in the last 52 weeks. The beta is 0.73, so ADX:PUREHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -30.56% |
| 50-Day Moving Average | 2.58 |
| 200-Day Moving Average | 2.73 |
| Relative Strength Index (RSI) | 15.59 |
| Average Volume (20 Days) | 3,848,489 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADX:PUREHEALTH had revenue of AED 27.31 billion and earned 2.00 billion in profits. Earnings per share was 0.18.
| Revenue | 27.31B |
| Gross Profit | 6.73B |
| Operating Income | 2.67B |
| Pretax Income | 2.24B |
| Net Income | 2.00B |
| EBITDA | 3.53B |
| EBIT | 2.67B |
| Earnings Per Share (EPS) | 0.18 |
Full Income Statement Balance Sheet
The company has 7.71 billion in cash and 18.22 billion in debt, with a net cash position of -10.52 billion or -0.95 per share.
| Cash & Cash Equivalents | 7.71B |
| Total Debt | 18.22B |
| Net Cash | -10.52B |
| Net Cash Per Share | -0.95 |
| Equity (Book Value) | 18.32B |
| Book Value Per Share | 1.65 |
| Working Capital | 5.21B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 4.93 billion and capital expenditures -938.88 million, giving a free cash flow of 3.99 billion.
| Operating Cash Flow | 4.93B |
| Capital Expenditures | -938.88M |
| Depreciation & Amortization | 863.47M |
| Net Borrowing | -2.66B |
| Free Cash Flow | 3.99B |
| FCF Per Share | 0.36 |
Full Cash Flow Statement Margins
Gross margin is 24.65%, with operating and profit margins of 9.76% and 7.33%.
| Gross Margin | 24.65% |
| Operating Margin | 9.76% |
| Pretax Margin | 8.21% |
| Profit Margin | 7.33% |
| EBITDA Margin | 12.92% |
| EBIT Margin | 9.76% |
| FCF Margin | 14.61% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.55%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 1.55% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 17.50% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 1.55% |
| Earnings Yield | 9.48% |
| FCF Yield | 18.90% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADX:PUREHEALTH has an Altman Z-Score of 1.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 4 |